The Mexico cataract surgery devices market has developed steadily over the years, shaped by the country’s expanding healthcare infrastructure, rising awareness about eye health, and growing demand from its aging population. Historically, cataract treatment in Mexico was limited to manual surgical techniques performed primarily in public hospitals and charitable clinics, often serving low-income and rural populations. Over the past three decades, however, Mexico has undergone a transformation in ophthalmic care. The introduction of advanced technologies such as phacoemulsification, foldable intraocular lenses (IOLs), and improved microsurgical equipment revolutionized cataract surgery in the country, making procedures safer, faster, and more accessible. As these innovations spread across private and public healthcare facilities, cataract surgery shifted from being a vision-saving necessity to a high-precision procedure that also improves the quality of vision, positioning Mexico as one of the leading markets for modern ophthalmic devices in Latin America. The Federal Commission for the Protection against Sanitary Risk (COFEPRIS) oversees the approval, monitoring, and importation of medical devices, including those used in cataract surgery.

Manufacturers must comply with local standards, obtain sanitary registration, and adhere to labeling and post-market surveillance requirements. The government has also introduced initiatives to improve access to ophthalmic care under programs like “Salud Visual,” which promotes eye health awareness and supports cataract treatment in underserved communities. Public health institutions such as IMSS (Mexican Social Security Institute) and ISSSTE (Institute for Social Security and Services for State Workers) provide free or subsidized cataract surgeries, creating a stable demand for basic surgical devices and consumables.According to the research report, " Mexico Cataract Surgery Devices Market Research Report, 2030," published by Actual Market Research, the Mexico Cataract Surgery Devices market is anticipated to add to USD 50 Million by 2025–30. The country’s aging population, coupled with rising cases of diabetes a major risk factor for cataract has significantly increased the need for cataract procedures. Additionally, greater urbanization and better access to healthcare services in cities like Mexico City, Guadalajara, and Monterrey have encouraged more people to seek timely surgical treatment rather than delaying until advanced vision loss. The increasing number of ophthalmology clinics, both public and private, has expanded the patient base, while growing awareness campaigns by organizations such as the Mexican Society of Ophthalmology have educated citizens about early detection and modern surgical options. Technological advancements are also reshaping Mexico’s cataract devices market.

The adoption of femtosecond laser-assisted cataract surgery, though still in early stages, is gradually increasing in urban private hospitals and specialized centers. This technology offers greater precision and reproducibility, improving post-operative outcomes and reducing surgical risks. Meanwhile, the latest phacoemulsification systems with advanced fluidics and energy control are gaining traction for their ability to shorten surgery times and improve patient recovery. Additionally, digital diagnostic devices and AI-powered imaging tools are becoming more common, enhancing pre-surgical assessments and custom lens selection, thereby boosting procedural accuracy. These innovations align with Mexico’s broader healthcare modernization efforts and its focus on integrating digital health technologies to improve treatment efficiency. The Mexico cataract surgery devices market is expected to grow as healthcare investments rise and medical tourism expands, with international patients seeking affordable, high-quality eye care.

Increasing collaboration between private clinics and global device manufacturers is also expected to introduce more advanced technologies at competitive prices.Intraocular lenses (IOLs) dominate the market, reflecting Mexico’s rising cataract surgery volume driven by an aging population and increasing prevalence of diabetes-related eye disorders. Standard monofocal lenses are widely used in public hospitals due to cost efficiency and coverage under national healthcare programs like INSABI and IMSS, while premium IOLs including multifocal, toric, and accommodating variants are gaining traction in private hospitals and specialty clinics catering to middle- and upper-income groups seeking better postoperative visual outcomes. Phacoemulsification systems, which enable minimally invasive cataract removal, are becoming the gold standard in urban surgical centers as surgeons move away from manual extracapsular techniques. Companies such as Alcon, Zeiss, and Bausch + Lomb maintain strong market presence, providing modern systems suited for both high-end and resource-limited facilities. Ophthalmic viscoelastic devices (OVDs) see consistent demand due to their critical role in maintaining intraocular space and minimizing surgical trauma, while the adoption of femtosecond laser systems though currently limited due to high capital costs is slowly increasing among private eye hospitals and centers specializing in refractive and cataract laser procedures. The other devices category, including micro-surgical instruments, forceps, knives, and disposable consumables, supports both small-scale clinics and large hospitals, ensuring widespread access to cataract care.Hospitals, both public and private, form the backbone of the market, handling a majority of cataract surgeries under the national health insurance system and through charitable programs that target underserved rural populations.

These hospitals typically utilize standard IOLs and conventional phacoemulsification systems, though major urban facilities in Mexico City, Guadalajara, and Monterrey are increasingly adopting femtosecond laser platforms and premium lens implants. Ambulatory surgery centers are growing rapidly as the government and private investors promote outpatient care models to improve surgical efficiency, reduce hospital burdens, and lower waiting times. These centers often operate with cost-effective setups, offering affordable cataract procedures to a broader population segment. Ophthalmology clinics especially those operated by independent surgeons or private eye-care chains focus on personalized cataract management, diagnostic services, and elective surgeries, often providing premium lens options and advanced technologies for patients willing to pay out of pocket. Meanwhile, academic and research institutes, such as UNAM’s Institute of Ophthalmology “Conde de Valenciana,” play a crucial role in ophthalmic education, clinical research, and technology adoption, collaborating with device manufacturers to train new surgeons and test innovative surgical techniques.Considered in this report• Historic Year: 2019• Base year: 2024• Estimated year: 2025• Forecast year: 2030Aspects covered in this report• Cataract Surgery Devices Market with its value and forecast along with its segments• Various drivers and challenges• On-going trends and developments• Top profiled companies• Strategic recommendationBy Product Type• Intra-ocular Lenses (IOL)• Phacoemulsification Systems• Ophthalmic Viscoelastic Devices• Femtosecond Laser Systems• Others (Knives and Low-Cost Consumables)By End User• Hospitals• Ambulatory Surgery Centers• Ophthalmology Clinics• Academic and Research Institutes.